Your browser doesn't support javascript.
loading
Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML.
Smith, Stephanie M; Zhang, Shiqi; Sundaram, Vandana; Roth, Michael; Andolina, Jeffrey R; Schapira, Lidia; Sakamoto, Kathleen M; Kolb, E Anders; Hijiya, Nobuko; Chaudhury, Sonali.
Affiliation
  • Smith SM; Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Stanford University School of Medicine, Palo Alto, California, USA.
  • Zhang S; Department of Medicine, Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, California, USA.
  • Sundaram V; Department of Medicine, Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, California, USA.
  • Roth M; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Andolina JR; Department of Pediatrics, Golisano Children's Hospital, University of Rochester Medical Center, Rochester, New York, USA.
  • Schapira L; Department of Medicine, Division of Oncology, Stanford Cancer Institute and Stanford University School of Medicine, Palo Alto, California, USA.
  • Sakamoto KM; Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Stanford University School of Medicine, Palo Alto, California, USA.
  • Kolb EA; Department of Pediatrics, Nemours/Alfred I. duPont Hospital for Children, Nemours Center for Cancer and Blood Disorders, Wilmington, Delaware, USA.
  • Hijiya N; Pediatric Hematology, Oncology, and Stem Cell Transplant, Columbia University Irving Medical Center, New York, New York, USA.
  • Chaudhury S; Department of Pediatrics, Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Pediatr Hematol Oncol ; 39(5): 453-467, 2022 Aug.
Article in En | MEDLINE | ID: mdl-34918996

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Physicians / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Graft vs Host Disease Type of study: Etiology_studies / Guideline / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Child / Humans Language: En Journal: Pediatr Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Physicians / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Graft vs Host Disease Type of study: Etiology_studies / Guideline / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Child / Humans Language: En Journal: Pediatr Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2022 Document type: Article Affiliation country: Country of publication: